Passage Bio (PASG)
(Real Time Quote from BATS)
$7.12 USD
-0.43 (-5.70%)
Updated Sep 19, 2025 03:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PASG 7.12 -0.43(-5.70%)
Will PASG be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PASG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PASG
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet
Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade
PASG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Passage Bio (PASG) Upgraded to Buy: Here's What You Should Know
Other News for PASG
Is PASG primed for upward momentum? Crossed Above 20 Day Moving Average shows up after rocketing 7.4%
PASG Fell Below 20 Day Moving Average on September 17
Lynx1 Capital Management LP Increases Stake in Passage Bio Inc
PASG Crossed Above 20 Day Moving Average on September 16
Is PASG ready to make a move? Bollinger Band Squeeze shows up after sliding 0.71%